ArticleBMC medical genomics2026
The heterozygous c.2241G>C variation in FGFR2 may cause autosomal dominant Kirner's deformity in a Chinese Han pedigree.
Article in BMC medical genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveKirner’s deformity is a progressive deformity of the distal phalange of the little finger in a volar and radial direction. The FGFR2 gene plays a critical role in skeletal development and growth, with abnormal expression and activation of FGFR2 being associated with skeletal abnormalities. This study presents a family with Kirner’s deformity involving multiple patients.
methodsWhole-exome sequencing was performed. SIFT, MutationTaster and Gerp+, while Clustal Omega was used for conservative analysis. In addition, I-TASSER was used to predict the 3D protein model. PyMOL was used for comparative analysis between abnormal and normal proteins.
resultsSequencing data revealed that the proband, affected father, and son all carried a heterozygous missense variation c.2241G>C (p. Q747H) in FGFR2. Bioinformatic analysis suggested the potential pathogenicity of this variation. While the spatial structure of the protein variant was not significantly altered, the FGFR2 variation (p.Q747H) disrupted a hydrogen bond between Gln 747 and Ser 746, leading to significant changes in ligand and enzyme binding active sites. This structural alteration is predicted to impair binding to the Mg2+ ligand, thereby potentially disrupting downstream signaling pathways. This proposed mechanism provides a plausible explanation for the observed abnormal expression of bone development genes.
conclusionThese findings are consistent with a model in which the novel FGFR2 variant could impair protein function, a hypothesis that warrants further investigation. Our study identifies a new variant in the variational spectrum of Kirner’s deformity and expands the variational spectrum of the FGFR2 gene.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.